Barchart.com
[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Never miss an Options trading signal: Unusual Options Activity and Options Screeners with Barchart Premier. FREE 30 Day Trial
Menu
Stocks | Futures | Watchlist | News | More
 
or
Watchlist | Portfolio | Dashboard
Site News
Contact
Market:
Faster, Cleaner, Better.

Lucid Diagnostics Inc (LUCD)

Lucid Diagnostics Inc (LUCD)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Notes
Alerts
Watch
Help
Go To:
PAVmed Provides Business Update and Reports First Quarter 2026 Financial Results PR Newswire - Fri May 15, 7:00AM CDT

Veris Health progressed commercial expansion and advanced implantable physiological monitor development toward FDA submission

LUCD : 0.9607 (-1.78%)
PAVM : 5.00 (+2.25%)
MarketBeat.com
Lucid Diagnostics Q1 Earnings Call Highlights MarketBeat - Thu May 14, 12:10PM CDT

Lucid Diagnostics (NASDAQ:LUCD) reported first-quarter 2026 EsoGuard test volume above its pre-Medicare target range, while management said it continues to await a Medicare local coverage determination...

LUCD : 0.9607 (-1.78%)
Lucid Diagnostics Provides Business Update and Reports First Quarter 2026 Financial Results PR Newswire - Thu May 14, 7:00AM CDT

Processed 3,177 EsoGuard ® tests and recognized 1Q26 revenue of $1.3 million, ending quarter with $45 million in proforma cash and a runway that extends into 2027 and past upcoming reimbursement...

LUCD : 0.9607 (-1.78%)
PAVM : 5.00 (+2.25%)
PAVmed to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 15, 2026 PR Newswire - Fri May 1, 7:31AM CDT

Conference Call and Webcast at 8:30 AM ET

LUCD : 0.9607 (-1.78%)
PAVM : 5.00 (+2.25%)
Lucid Diagnostics to Hold First Quarter 2026 Business Update Conference Call and Webcast on May 14, 2026 PR Newswire - Thu Apr 30, 7:31AM CDT

Conference Call and Webcast at 8:30 AM ET

LUCD : 0.9607 (-1.78%)
PAVM : 5.00 (+2.25%)
Lucid Diagnostics Announces Closing of $18 Million Underwritten Offering of Common Stock PR Newswire - Fri Apr 24, 9:23AM CDT

NEW YORK , April 24, 2026 /PRNewswire/ -- Lucid Diagnostics Inc.  (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary...

LUCD : 0.9607 (-1.78%)
PAVM : 5.00 (+2.25%)
Lucid Diagnostics Announces $18 Million Underwritten Offering of Common Stock PR Newswire - Thu Apr 23, 7:30AM CDT

NEW YORK , April 23, 2026 /PRNewswire/ -- Lucid Diagnostics Inc.  (Nasdaq: LUCD) ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company, and subsidiary...

LUCD : 0.9607 (-1.78%)
PAVM : 5.00 (+2.25%)
Lucid Diagnostics to Participate in Fireside Chat at the 25th Annual Needham Virtual Healthcare Conference PR Newswire - Thu Apr 9, 7:01AM CDT

NEW YORK , April 9, 2026 /PRNewswire/ --  Lucid Diagnostics Inc.   (Nasdaq: LUCD)  ("Lucid" or the "Company"), a commercial-stage, cancer prevention medical diagnostics company...

LUCD : 0.9607 (-1.78%)
PAVM : 5.00 (+2.25%)
PAVmed Appoints Joseph Virgilio to Lead Relaunched Medical Device Portfolio PR Newswire - Thu Apr 2, 7:01AM CDT

Medtech industry veteran to oversee development and commercialization of PAVmed's current and future medical device portfolio.

LUCD : 0.9607 (-1.78%)
PAVM : 5.00 (+2.25%)
PAVmed Provides Business Update and Reports Fourth Quarter and Full Year 2025 Financial Results PR Newswire - Mon Mar 30, 7:00AM CDT

PAVmed strengthened its capital structure and relaunched its medical device portfolio under new leadership

LUCD : 0.9607 (-1.78%)
PAVM : 5.00 (+2.25%)

Barchart Exclusives

Home Depot or Lowe’s: 1 Has Raised Its Dividend for 50+ Years. The Other Pays More Now Barchart - Fri Jun 12, 6:00PM CDT
Home Depot and Lowe’s both offer similar appeal, but valuation, yield, and dividend-growth history make this matchup closer than it looks. Read more
Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.